Exelead, a MilliporeSigma company, is a biopharmaceutical company specializing in developing and manufacturing LNP, liposome, and pegylated formulations. Headquartered in Indiana, USA, Exelead supports their partners at every stage of their product’s life cycle with preclinical development, clinical supply, and commercial contract manufacturing solutions, including sterile products and LNP formulation development. The company’s robust LNP capabilities includes process development, analytical methods development and testing, GMP manufacturing, GMP aseptic filling, and tech transfer.